Skip to content

Opening book details…

About this Medicine article

A first-in-human study of PDC31 (prostaglandin F2 receptor inhibitor) in primary dysmenorrhea by Bottcher, B.; Laterza, R. M.; Wildt, L.; Seufert, R. J.; Buhling, K. J.; Singer, C. F.; Hill, W.; Griffin, P.; Jilma, B.; Schulz, M.; Smith, R. P. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Bottcher, B.; Laterza, R. M.; Wildt, L.; Seufert, R. J.; Buhling, K. J.; Singer, C. F.; Hill, W.; Griffin, P.; Jilma, B.; Schulz, M.; Smith, R. P.
Publisher
Oxford University Press; Oxford University Press (OUP) (ISSN 0268-1161)
Published
2014
Field
Medicine (Health Sciences)

More by Bottcher, B.; Laterza, R. M.; Wildt, L.; Seufert, R. J.; Buhling, K. J.; Singer, C. F.; Hill, W.; Griffin, P.; Jilma, B.; Schulz, M.; Smith, R. P.

Browse all works by Bottcher, B.; Laterza, R. M.; Wildt, L.; Seufert, R. J.; Buhling, K. J.; Singer, C. F.; Hill, W.; Griffin, P.; Jilma, B.; Schulz, M.; Smith, R. P.